Testing effectiveness (Phase 2)Looking for participantsNCT06195072
What this trial is testing
Platform Clinical Study for Conquering Scleroderma
Who this might be right for
Interstitial Lung Disease Due to Systemic DiseaseScleroderma
Scleroderma Research Foundation, Inc. 400